Pro-Dex, Inc. (PDEX)
NASDAQ: PDEX · Real-Time Price · USD
35.70
-0.69 (-1.90%)
At close: Sep 10, 2025, 4:00 PM
35.46
-0.24 (-0.67%)
After-hours: Sep 10, 2025, 4:34 PM EDT
Company Description
Pro-Dex, Inc. designs, develops, manufactures, and sells powered surgical instruments for medical device original equipment manufacturers worldwide.
It offers autoclavable, battery-powered and electric, and multi-function surgical drivers and shavers that are primarily used in the orthopedic, thoracic, and craniomaxillofacial markets.
The company also provides engineering, quality, and regulatory consulting services; and manufactures and sells rotary air motors to various industries.
Its products are used in hospitals, medical engineering labs, scientific research facilities, and high-tech manufacturing operations.
Pro-Dex, Inc. was founded in 1978 and is headquartered in Irvine, California.
Pro-Dex, Inc.
Country | United States |
Founded | 1978 |
Industry | Medical Instruments & Supplies |
Sector | Healthcare |
Employees | 181 |
CEO | Richard Van Kirk |
Contact Details
Address: 2361 McGaw Avenue Irvine, California 92614 United States | |
Phone | 949 769 3200 |
Website | pro-dex.com |
Stock Details
Ticker Symbol | PDEX |
Exchange | NASDAQ |
Stock Type | Common Stock |
Fiscal Year | July - June |
Reporting Currency | USD |
CIK Code | 0000788920 |
CUSIP Number | 74265M205 |
ISIN Number | US74265M2052 |
Employer ID | 84-1261240 |
SIC Code | 3841 |
Key Executives
Name | Position |
---|---|
Richard Lee Van Kirk Jr. | Chief Executive Officer, President and Director |
Alisha K. Charlton | Chief Financial Officer and Corporate Secretary |
Chris Jackson | Directors of Operations |
Latest SEC Filings
Date | Type | Title |
---|---|---|
Sep 4, 2025 | 8-K | Current Report |
Sep 4, 2025 | 10-K | Annual Report |
Aug 15, 2025 | 8-K | Current Report |
Jun 5, 2025 | 8-K | Current Report |
May 30, 2025 | SD | Form - SD |
May 1, 2025 | 8-K | Current Report |
May 1, 2025 | 10-Q | Quarterly Report |
Apr 11, 2025 | 8-K | Current Report |
Apr 4, 2025 | SCHEDULE 13D/A | Filing |
Apr 2, 2025 | 144 | Filing |